Mayer - Rokitansky - Kuster - Hauser (MRKH) syndrome
Conditions
Interventions
None listed
Sponsors
Vrije Universiteit Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients: - Diagnosed with MRKH syndrome - 18 - 50 years;Control group: (already sampled as control patients in a previous study) - 18 - 50 jaar
Exclusion criteria
Exclusion criteria: - not willing or able to sign the informed consent - reported pregnancy (in the control group)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The presence of chimerism in MRKH patients, determined by Y-chromosome-specific real-time quantitative polymerase chain reaction. | — |
Secondary
| Measure | Time frame |
|---|---|
| In addition we want to test if the chimerism is only confined to blood, by testing (micro)chimerism in non-hematopoietic tissue (buccal smear) in MRKH patients. If the chimerism is present in the blood, but not in this non-hematopoietic tissue, this supports the idea that the chimerism is a result of blood sharing via intrauterine placental connections. | — |
Countries
Netherlands
Outcome results
None listed